Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Economy

Eyenovia to end eye drug study, cut 50% of its workforce

admin by admin
November 16, 2024
in Economy
0
Eyenovia to end eye drug study, cut 50% of its workforce
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

(Reuters) -Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

Shares of the company were down nearly 70% at close of trading on Friday.

The drug, a low-dose atropine, was being tested with the company’s experimental drug-delivery device, Optejet, as a potential treatment for progressive myopia in children aged between 3 and 12.

An independent committee reviewed the safety and efficacy data from 252 trial participants and found that the rate of myopia progression was not significantly different between the treatment arm and placebo.

All doses of the drug appeared to be well-tolerated with “mild and infrequent” side-effects, the company said.

Optejet delivers the drug in microdoses and reduces chances of overdosing compared to conventional eyedroppers, according to the company.

The drug developer said it plans to review the data more thoroughly and evaluate strategic options, including a business combination, reverse merger and/or sale of assets.

The company said its remaining staff will be focused on the development of the second generation of Optejet.

Earlier this year, Eyenovia (NASDAQ:EYEN) had gained U.S. approval for its eye drops to reduce inflammation and pain in patients who have undergone eye surgery.

The company also markets a pupil-dilating spray, Mydcombi, for use with Optejet during eye examinations.

This post appeared first on investing.com

Previous Post

Mexico budget proposal trims 2025 deficit, sees better growth

Next Post

While farmers protest, UK’s Starmer says will defend budget ‘all day long’

admin

admin

Next Post
While farmers protest, UK’s Starmer says will defend budget ‘all day long’

While farmers protest, UK’s Starmer says will defend budget ‘all day long’

Trending News

Fed to “get pushed into deeper” rate cuts in 2024 – BofA

Fed to “get pushed into deeper” rate cuts in 2024 – BofA

September 19, 2024
Ferrari stock is severely overvalued: is it an attractive buy?

Ferrari stock is severely overvalued: is it an attractive buy?

September 29, 2024
Canada faces worsening home ownership crisis with stalled condo sales

Canada faces worsening home ownership crisis with stalled condo sales

October 30, 2024
Subscribe to Insightful Word


    Recent News

    China’s May export growth seen slowing to 5.0% amid trade uncertainty: Reuters poll

    China’s May export growth seen slowing to 5.0% amid trade uncertainty: Reuters poll

    June 6, 2025
    FTSE 100 Index shares of 2025: Rolls-Royce, Fresnillo, BAE, and more

    FTSE 100 Index shares of 2025: Rolls-Royce, Fresnillo, BAE, and more

    June 6, 2025
    Asian stocks end mixed: Hang Seng snaps winning streak, Nikkei jumps 0.5%

    Asian stocks end mixed: Hang Seng snaps winning streak, Nikkei jumps 0.5%

    June 6, 2025
    Starlink reportedly secures key licence in India, moves closer to launching services

    Starlink reportedly secures key licence in India, moves closer to launching services

    June 6, 2025

    Recent News

    China’s May export growth seen slowing to 5.0% amid trade uncertainty: Reuters poll

    China’s May export growth seen slowing to 5.0% amid trade uncertainty: Reuters poll

    June 6, 2025
    FTSE 100 Index shares of 2025: Rolls-Royce, Fresnillo, BAE, and more

    FTSE 100 Index shares of 2025: Rolls-Royce, Fresnillo, BAE, and more

    June 6, 2025

    Latest News

    • China’s May export growth seen slowing to 5.0% amid trade uncertainty: Reuters poll
    • FTSE 100 Index shares of 2025: Rolls-Royce, Fresnillo, BAE, and more
    • Asian stocks end mixed: Hang Seng snaps winning streak, Nikkei jumps 0.5%

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.